We are live on ! Find out more

iShares US Medical Devices ETF

IHI

Market cap $3.63B

55.69 USD

+1.05

1.92%

At close Updated Oct 29, 4:00 PM EDT

Pre-market

After hours

55.65

-0.04

0.07%

1 day

1.92%

5 days

1.94%

1 month

7.53%

3 months

4.48%

6 months

10.65%

Year to date

-10.02%

1 year

-8.82%

5 years

-14.87%

10 years

147.73%

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 0%

Neutral 75%

Negative 25%

IHI and Bristol Myers Squibb Launch National Collaborative to Expand Access to Cancer Clinical Trials

BOSTON--(BUSINESS WIRE)--IHI, in partnership with Bristol Myers Squibb (BMS), is launching a new Cancer Collective Action Collaborative.

IHI and Bristol Myers Squibb Launch National Collaborative to Expand Access to Cancer Clinical Trials

IHI Appoints Dr. Amar Shah as Chief Scientific Officer

BOSTON--(BUSINESS WIRE)--IHI today announced the appointment of Amar Shah, MBBS, FRCPsych, LLM, MA, MBA, MBE, as permanent Chief Scientific Officer (CSO).

IHI Appoints Dr. Amar Shah as Chief Scientific Officer

Zacks Investment Research

Should You Invest in the iShares U.S. Medical Devices ETF (IHI)?

Looking for broad exposure to the Healthcare - Medical Devices segment of the equity market? You should consider the iShares U.S. Medical Devices ETF (IHI), a passively managed exchange traded fund launched on May 1, 2006.

Should You Invest in the iShares U.S. Medical Devices ETF (IHI)?

IHI: Limited Upside With Unfavorable Risk-Reward

iShares U.S. Medical Devices ETF is rated a sell due to historical underperformance, high concentration risk, and elevated valuation. IHI's top three holdings—ABT, ISRG, SYK—comprise nearly 43% of the portfolio, amplifying downside risk if growth falters or valuations compress. The ETF's 34x PE and sub-0.5% yield create an unattractive risk-reward profile, especially given its 18–20% volatility and minimal income.

IHI: Limited Upside With Unfavorable Risk-Reward

Zacks Investment Research

Should You Invest in the iShares U.S. Medical Devices ETF (IHI)?

Launched on May 1, 2006, the iShares U.S. Medical Devices ETF (IHI) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Medical Devices segment of the equity market.

Should You Invest in the iShares U.S. Medical Devices ETF (IHI)?

IHI: Pressured Consumers, Unclear Healthcare Policy, Weak Price Action

I reiterate a Hold rating on the iShares US Medical Devices ETF despite its 20% YTD decline and ongoing technical weakness. IHI's valuation is reasonable but not compelling, with a P/E of 18.8x and a 10.3% long-term EPS growth rate. The ETF is highly concentrated, with its top 10 holdings accounting for 75% of the portfolio and a low dividend yield at 0.45%.

IHI: Pressured Consumers, Unclear Healthcare Policy, Weak Price Action

Zacks Investment Research

The Silver Tsunami: Healthcare ETFs to Buy Amid Aging US Demographics

ETFs like XLV stand out as aging U.S. demographics fuel rising demand for healthcare, medical devices and senior-focused care.

The Silver Tsunami: Healthcare ETFs to Buy Amid Aging US Demographics

Dynamic Aerospace Systems (OTCQB:BRQL) to Host Delegation from Mitsubishi Heavy Industries, Kawasaki Heavy Industries, Subaru, NEC, IHI and Other Japanese Defense Leaders Following DPS Drone Expo

ANN ARBOR, MI / ACCESS Newswire / May 6, 2026 / Dynamic Aerospace Systems Corporation (OTCQB:BRQL), a U.S.-based manufacturer of unmanned aerial systems (UAS), announced it will host a Japanese defense and industrial delegation on May 15, 2026, at its Ann Arbor facility to evaluate its drone platforms in live operational demonstrations. The delegation includes representatives from major defense and industrial organizations, including the Japan Defense Technology Foundation, Mitsubishi Heavy Industries, Ltd.

Dynamic Aerospace Systems (OTCQB:BRQL) to Host Delegation from Mitsubishi Heavy Industries, Kawasaki Heavy Industries, Subaru, NEC, IHI and Other Japanese Defense Leaders Following DPS Drone Expo

Medical Technology Stocks: Innovation Endures As Valuations Reset

Investors are questioning the staying power of medical technology (medtech) stocks, which have fallen from grace since the COVID-19 pandemic. The starting point is to distinguish between medtech and other healthcare industries.

Medical Technology Stocks: Innovation Endures As Valuations Reset

Zacks Investment Research

Should You Invest in the iShares U.S. Medical Devices ETF (IHI)?

Launched on May 1, 2006, the iShares U.S. Medical Devices ETF (IHI) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Medical Devices segment of the equity market.

Should You Invest in the iShares U.S. Medical Devices ETF (IHI)?

See News Rankings

Price charts implemented using Lightweight Charts™